Terms: = Breast cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Prognosis
46 results:
1. jak2 Loss Arising From Tumor-Spread-Through-Air-Spaces (STAS) Promotes Tumor Progression by Suppressing CD8+ T Cells in Lung Adenocarcinoma: A Machine Learning Approach.
Choi S; Kim HS; Min KW; Noh YK; Lee JY; Moon JY; Jung US; Kwon MJ; Kim DH; Son BK; Pyo JS; Ro SK
J Korean Med Sci; 2024 Jan; 39(2):e16. PubMed ID: 38225784
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of the association of Janus kinase 2 mutations with the response to immune checkpoint inhibitor therapy.
Chen P; Long J; Zhang J; Xie F; Wu W; Tian Z; Zhang S; Yu K
Inflamm Res; 2024 Feb; 73(2):263-276. PubMed ID: 38200372
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive breast cancer: A comprehensive Literature Review.
Yu Q; Xu C; Song J; Jin Y; Gao X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117322. PubMed ID: 37866466
[TBL] [Abstract] [Full Text] [Related]
4. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.
Morrow E; Pennel K; Hatthakarnkul P; Leslie H; Mallon E; Andersen D; Jamieson N; McMillan D; Roseweir A; Edwards J
Cancer Med; 2023 Jun; 12(12):13225-13240. PubMed ID: 37199043
[TBL] [Abstract] [Full Text] [Related]
5. BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer.
Wu H; Xiang Z; Huang G; He Q; Song J; Dou R; Yang C; Wang S; Xiong B
Int J Biol Sci; 2023; 19(2):465-483. PubMed ID: 36632455
[TBL] [Abstract] [Full Text] [Related]
6. AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance.
Ng ASN; Zhang S; Mak VCY; Zhou Y; Yuen Y; Sharma R; Lu Y; Zhuang G; Zhao W; Pang HH; Cheung LWT
Cell Rep; 2022 Dec; 41(11):111821. PubMed ID: 36516775
[TBL] [Abstract] [Full Text] [Related]
7. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract] [Full Text] [Related]
8. Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy.
Patra I; Naser RH; Hussam F; Hameed NM; Kadhim MM; Ahmad I; Awadh SA; Hamad DA; Parra RMR; Mustafa YF
Mol Biol Rep; 2023 Jan; 50(1):85-95. PubMed ID: 36309613
[TBL] [Abstract] [Full Text] [Related]
9. Myeloid Sarcoma of the breast as Blast Phase of jak2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review.
Pace M; Guadagno E; Russo D; Gencarelli A; Carlea A; Di Spiezio A; Bertuzzi C; Mascolo M; Grimaldi F; Insabato L
Pathobiology; 2023; 90(2):123-130. PubMed ID: 35850113
[TBL] [Abstract] [Full Text] [Related]
10. Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders.
Lin PH; Tseng LM; Lee YH; Chen ST; Yeh DC; Dai MS; Liu LC; Wang MY; Lo C; Chang S; Tan KT; Chen SJ; Kuo SH; Huang CS
J Formos Med Assoc; 2022 Dec; 121(12):2538-2547. PubMed ID: 35752529
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent.
Rauf A; Shariati MA; Imran M; Bashir K; Khan SA; Mitra S; Emran TB; Badalova K; Uddin MS; Mubarak MS; Aljohani ASM; Alhumaydhi FA; Derkho M; Korpayev S; Zengin G
Environ Sci Pollut Res Int; 2022 May; 29(21):31025-31041. PubMed ID: 35119637
[TBL] [Abstract] [Full Text] [Related]
12. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract] [Full Text] [Related]
13. Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway.
Shen J; Wang M; Li F; Yan H; Zhou J
Bioengineered; 2022 Jan; 13(1):1335-1345. PubMed ID: 34983296
[TBL] [Abstract] [Full Text] [Related]
14. Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets jak2/STAT3 Signaling, Migration and Invasion of Triple-Negative breast cancer Cells.
Bouaouiche S; Ghione S; Sghaier R; Burgy O; Racoeur C; Derangère V; Bettaieb A; Plenchette S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445170
[TBL] [Abstract] [Full Text] [Related]
15. CTR9-mediated jak2/STAT3 pathway promotes the proliferation, migration, and invasion of human glioma cells.
Xu Y; Chen J; He G; Zhang Y
J Clin Lab Anal; 2021 Sep; 35(9):e23943. PubMed ID: 34369006
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with breast cancer.
Al-Shamsi HO; Abu-Gheida I; Abdulsamad AS; AlAwadhi A; Alrawi S; Musallam KM; Arun B; Ibrahim NK
Oncologist; 2021 Nov; 26(11):e2086-e2089. PubMed ID: 34327780
[TBL] [Abstract] [Full Text] [Related]
17. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.
Lin L; Wen J; Lin B; Xia E; Zheng C; Ye L; Wang Y; Wang O; Chen Y
Hum Cell; 2021 May; 34(3):901-917. PubMed ID: 33665786
[TBL] [Abstract] [Full Text] [Related]
18. CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
Wang F; Wang X; Li J; Lv P; Han M; Li L; Chen Z; Dong L; Wang N; Gu Y
J Biomed Sci; 2021 Jan; 28(1):4. PubMed ID: 33397365
[TBL] [Abstract] [Full Text] [Related]
19. jak2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor.
Liu Q; Ai B; Kong X; Wang X; Qi Y; Wang Z; Fang Y; Wang J
Int Immunopharmacol; 2021 Jan; 90():107186. PubMed ID: 33290964
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
[Next]
